Limits...
Obesity might be a good prognosis factor for COPD patients using domiciliary noninvasive mechanical ventilation

View Article: PubMed Central - PubMed

ABSTRACT

Cachexia is known to be a deteriorating factor for survival of patients with chronic obstructive pulmonary disease (COPD), but data related to obesity are limited. We observed that obese patients with COPD prescribed long-term noninvasive mechanical ventilation (NIMV) had better survival rate compared to nonobese patients. Therefore, we conducted a retrospective observational cohort study. Archives of Thoracic Diseases Training Hospital were sought between 2008 and 2013. All the subjects were prescribed domiciliary NIMV for chronic respiratory failure secondary to COPD. Subjects were grouped according to their body mass index (BMI). The first group consisted of subjects with BMI between 20 and 30 kg/m2, and the second group consisted of subjects with BMI >30 kg/m2. Data obtained at the first month’s visit for the following parameters were recorded: age, sex, comorbid diseases, smoking history, pulmonary function test, 6-minute walk test (6-MWT), and arterial blood gas analysis. Hospital admissions were recorded before and after the domiciliary NIMV usage. Mortality rate was searched from the electronic database. Overall, 118 subjects were enrolled. Thirty-eight subjects had BMI between 20 and 30 kg/m2, while 80 subjects had BMI >30 kg/m2. The mean age was 65.8±9.4 years, and 81% were male. The median follow-up time was 26 months and mortality rates were 32% and 34% for obese and nonobese subjects (P=0.67). Improvement in 6-MWT was protective against mortality. In conclusion, survival of obese patients with COPD using domiciliary NIMV was found to be better than those of nonobese patients, and the improvement in 6-MWT in such patients was found to be related to a better survival.

No MeSH data available.


Related in: MedlinePlus

CONSORT flow diagram.Abbreviations: BMI, body mass index; CONSORT, Consolidated Standards of Reporting Trials; COPD, chronic obstructive pulmonary disease; NIV, noninvasive ventilation; PaCO2, partial arterial carbon dioxide pressure; PFT, pulmonary function test.
© Copyright Policy
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4998020&req=5

f1-copd-11-1895: CONSORT flow diagram.Abbreviations: BMI, body mass index; CONSORT, Consolidated Standards of Reporting Trials; COPD, chronic obstructive pulmonary disease; NIV, noninvasive ventilation; PaCO2, partial arterial carbon dioxide pressure; PFT, pulmonary function test.

Mentions: We performed a retrospective observational cohort study. The study which is accordant with the Declaration of Helsinki, was approved by the local Ethics Committee of Sureyyapasa Thoracic Diseases Training Hospital and patient consent was not required. All the patients with CRF due to COPD treated at the Thoracic Diseases and Thoracic Surgery Training Government Hospital in Istanbul, Turkey, between January 2008 and August 2013 were included if they were prescribed domiciliary NIMV during their hospital discharge. The subjects with BMI between 20 and 30 kg/m2 were accepted as nonobese while those with BMI >30 kg/m2 were accepted as obese. We defined an index date, which was 1 month after the patients received their ventilators and were followed for a minimum of 1 year. The patient’s eligibility and enrollment are summarized on the Consolidated Standards of Reporting Trials flow diagram (Figure 1).


Obesity might be a good prognosis factor for COPD patients using domiciliary noninvasive mechanical ventilation
CONSORT flow diagram.Abbreviations: BMI, body mass index; CONSORT, Consolidated Standards of Reporting Trials; COPD, chronic obstructive pulmonary disease; NIV, noninvasive ventilation; PaCO2, partial arterial carbon dioxide pressure; PFT, pulmonary function test.
© Copyright Policy
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4998020&req=5

f1-copd-11-1895: CONSORT flow diagram.Abbreviations: BMI, body mass index; CONSORT, Consolidated Standards of Reporting Trials; COPD, chronic obstructive pulmonary disease; NIV, noninvasive ventilation; PaCO2, partial arterial carbon dioxide pressure; PFT, pulmonary function test.
Mentions: We performed a retrospective observational cohort study. The study which is accordant with the Declaration of Helsinki, was approved by the local Ethics Committee of Sureyyapasa Thoracic Diseases Training Hospital and patient consent was not required. All the patients with CRF due to COPD treated at the Thoracic Diseases and Thoracic Surgery Training Government Hospital in Istanbul, Turkey, between January 2008 and August 2013 were included if they were prescribed domiciliary NIMV during their hospital discharge. The subjects with BMI between 20 and 30 kg/m2 were accepted as nonobese while those with BMI >30 kg/m2 were accepted as obese. We defined an index date, which was 1 month after the patients received their ventilators and were followed for a minimum of 1 year. The patient’s eligibility and enrollment are summarized on the Consolidated Standards of Reporting Trials flow diagram (Figure 1).

View Article: PubMed Central - PubMed

ABSTRACT

Cachexia is known to be a deteriorating factor for survival of patients with chronic obstructive pulmonary disease (COPD), but data related to obesity are limited. We observed that obese patients with COPD prescribed long-term noninvasive mechanical ventilation (NIMV) had better survival rate compared to nonobese patients. Therefore, we conducted a retrospective observational cohort study. Archives of Thoracic Diseases Training Hospital were sought between 2008 and 2013. All the subjects were prescribed domiciliary NIMV for chronic respiratory failure secondary to COPD. Subjects were grouped according to their body mass index (BMI). The first group consisted of subjects with BMI between 20 and 30 kg/m2, and the second group consisted of subjects with BMI >30 kg/m2. Data obtained at the first month’s visit for the following parameters were recorded: age, sex, comorbid diseases, smoking history, pulmonary function test, 6-minute walk test (6-MWT), and arterial blood gas analysis. Hospital admissions were recorded before and after the domiciliary NIMV usage. Mortality rate was searched from the electronic database. Overall, 118 subjects were enrolled. Thirty-eight subjects had BMI between 20 and 30 kg/m2, while 80 subjects had BMI >30 kg/m2. The mean age was 65.8±9.4 years, and 81% were male. The median follow-up time was 26 months and mortality rates were 32% and 34% for obese and nonobese subjects (P=0.67). Improvement in 6-MWT was protective against mortality. In conclusion, survival of obese patients with COPD using domiciliary NIMV was found to be better than those of nonobese patients, and the improvement in 6-MWT in such patients was found to be related to a better survival.

No MeSH data available.


Related in: MedlinePlus